PRADAXA DEATHS & BLEEDING RAISE RED FLAGS FOR HEART DOCTORS
In a June 14, 2012, REUTERS, entitled: ”TOP HEART DOCTORS FRET OVER NEW BLOOD THINNERS“, Randsell Pierson reports on the serious concerns and trepidation being raised by medical providers and prescribers over “new” blood thinners. PRADAXA (DABIGATRAN) was the first “new generation” blood thinner marketed as a lifestyle change for users because it required little monitoring or dietary changes. However, it has proven to have life altering consequences when the effects of the blood thinner combine with a trauma, or underlying disease, which complicates the outcome drastically and can lead to death. A competitive, and potentially dangerous, problem surrounding PRADAXA (DABIGATRAN) and other new blood thinners is illustrated by the aggressive marketing competing pharmaceutical companies have created to promote their new branded products. Citing the ISMP (Institute for Safe Medication Practices) data discussed in our post below, REUTERS examines, in part, the origin of the problem and again highlights the fact that PRADAXA (DABIGATRAN) has no antidote or quick reversal agent.
While the article quotes physicians, the physicians do not address the fact that ISMP’s data has confirmed 542 deaths and PRADAXA (DABIGATRAN) tops the list of drugs linked to adverse event reports as discussed below. All drugs come with risks. However, you cannot agree to accept the risks, or consequences, if the manufacturer is not providing the warning or information to prescribers so they can in turn pass it on to patients. This is a subtle point to some, but it is at the heart of PRADAXA CASES and ongoing lawsuits. Dr. Richard Besdine, Director of the Center for Gerontology at Brown University, is quoted as stating “[i]f there’s an adverse event lurking in the closet for a new drug, it’s most likely to come out in patients that are old and frail and taking multiple medications. They’re the canary in the coal mine“. Would you want to volunteer to become the canary in the coal mine or advance warning of the potential consequences?
FREE CASE EVALUATIONS are available for patients that have suffered serious injuries, or bleeding events from the use of PRADAXA (DABIGATRAN) through use of the contact form below.